
---
title: '致远互联签约佛慈制药'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7627'
author: 证券时报网
comments: false
date: Mon, 05 Sep 2022 08:28:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7627'
---

<div>   
<p>证券时报e公司讯，近日，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688369" style="color: #2f67d1;text-decoration: none;" code="688369" target="_blank">致远互联</a>正式签约<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002644" style="color: #2f67d1;text-decoration: none;" code="002644" target="_blank">佛慈制药</a>。依托COP协同运营平台，助力<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002644" style="color: #2f67d1;text-decoration: none;" code="002644" target="_blank">佛慈制药</a>统一工作入口，打通业务流程，建立起数据共享、业务协同、管理联动的应用场景，推动<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002644" style="color: #2f67d1;text-decoration: none;" code="002644" target="_blank">佛慈制药</a>走向精细化、数智化管理，提升组织运营管理效率，为老字号发展注入数智运营新动能。</p>

                  
</div>
            